Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Compliance Certificate Under Reg 7(3) Of LODR For The Year Ended 31.03.2023

Compliance certificate under Reg 7(3) of LODR for the year ended 31.03.2023
15-04-2023
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Board Meeting Outcome for Appointment Of CS Vishnu Vasudeva Kuppa As Company Secretary And Compliance Officer Of The Company W.E.F 07.04.2023.

Appointment of CS Vishnu Vasudeva Kuppa as Company Secretary and Compliance Officer of the Company w.e.f 07.04.2023.
07-04-2023
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Board Meeting Intimation for To Consider The Appointment Of Company Secretary Cum Compliance Officer And Any Other Business With The Permission Of The Chair

BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/04/2023 ,inter alia, to consider and approve To consider the appointment of Company Secretary cum Compliance Officer and any other business with the permission of the Chair
04-04-2023
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2022

Unaudited financial results for the quarter and nine months ended 31.12.2022 along with limited review report
08-02-2023
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Board Meeting Intimation for Considering The Unaudited Results For The Nine Months Period And Quarter Ended 31.12.2022

BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 ,inter alia, to consider and approve the Unaudited Results for the Nine Months Period and Quarter ended 31.12.2022
01-02-2023
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Bafna Pharmaceuticals Limited Awarded With MSME-ZED Certified GOLD CERTIFICATE

Bafna Pharmaceuticals Limited is proud to announce that the Company has been awarded MSME ZED GOLD CERTFICATE by the Ministry of Micro, Small & Medium Enterprises, Government of India.
20-01-2023
Bigul

BAFNA PHARMACEUTICALS LTD. - 532989 - Announcement under Regulation 30 (LODR)-Resignation of Director

Resignation of Mr. Atul Sachdeva, as an Non Executive Non Independent Director of the Company with effect from 13th January, 2023.
19-01-2023
Next Page
Close

Let's Open Free Demat Account